Redeye: Norse Impact Q1 2023 - A notch in the growth trajetory
Redeye revises its estimates after reviewing Norse Impact’s Q1 2023 report. The quarter’s sales and profitability fell below expectations, primarily due to a prolonged B2B2C rollout timeline. As a result, Redeye lowers its valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/